Articles From: ACTV8.me Launches Personalized Proximity Platform™ for Retail, Travel, Hospitality and Sports/Entertainment Venues with NCR to Acxiom Increases Share Repurchase Authorization to $250 Million


2014/1/13
ACTV8.me announced today that, together with NCR (NYSE: NCR), it is set to deploy its Personalized Proximity Platform™ that empowers retailers, venues and brands to build timely, personal and transactional one-to-one relationships with consumers.
Sign-up for ACTV8.me Launches Personalized Proximity Platform™ for Retail, Travel, Hospitality and Sports/Entertainment Venues with NCR investment picks
2013/10/1
Acuity Brands, Inc. (NYSE: AYI) (“Company”) today announced record fourth quarter net sales and diluted earnings per share (“diluted EPS”). Fiscal 2013 fourth quarter net sales of $579.8 million increased $65.5 million, or 13 percent, compared with the year-ago period.
Sign-up for Acuity Brands Reports Fiscal 2013 Fourth Quarter and Full-Year Results investment picks
2014/4/2
ATLANTA, April 2, 2014 (GLOBE NEWSWIRE) -- Acuity Brands, Inc. (NYSE:AYI) ("Company") today announced fiscal 2014 second quarter net sales of $546.2 million, an increase of $59.5 million, or 12 percent, compared with the year-ago period.
Sign-up for Acuity Brands Reports Fiscal 2014 Second Quarter Results investment picks
2014/1/9
ATLANTA, Jan.
Sign-up for Acuity Brands Reports Record First Quarter Results investment picks
2014/3/3
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1094600&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Financial Results investment picks
2014/4/10
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1105649&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Return of Product Rights investment picks
2013/8/1
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1039302&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Second Quarter 2013 Financial Results investment picks
2013/10/9
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1058119&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Settlement of Oxecta(R) Patent Litigation With Par Pharmaceutical and Impax Laboratories investment picks
2013/8/26
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1045820&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Top-Line Results of a Clinical Study Assessing Abuse Liability investment picks
2014/4/10
By Michael Calia Acura Pharmaceuticals Inc. (ACUR) on Thursday said it reached a deal to terminate Pfizer Inc.'s (PFE) license for its Aversion technology.
Sign-up for Acura Pharmaceuticals Ends Licensing Pact With Pfizer investment picks
2013/10/10
By Saumya Vaishampayan, MarketWatch NEW YORK (MarketWatch) -- Shares of Acura Pharmaceuticals and Netflix jumped in premarket trade Thursday while shares of Citrix Systems and Quest Diagnostics tumbled.
Sign-up for Acura Pharmaceuticals leaps on patent settlement investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1074504&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug Development investment picks
2013/9/18
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1052135&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Provides Update on NEXAFED(R) Launch investment picks
2013/12/30
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1078767&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Secures $10.0 Million of Debt Financing investment picks
2014/2/18
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1090761&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals to Host 2013 Financial Results Conference Call on March 4, 2014 investment picks
2013/10/29
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1063058&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals to Host Third Quarter 2013 Financial Results Conference Call on November 5, 2013 investment picks
2014/3/5
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1095571&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference investment picks
2014/2/15
By Dan Neil Now, what was your handle there, partner?
Sign-up for Acura's RLX is a lovely car that's hard to love investment picks
Acusphere, Inc. (ACUSD.PK) today announced that Mark Leuchtenberger has been appointed President, Chief Executive Officer and a Director of the company, succeeding co-founder Sherri C.
Sign-up for Acusphere Appoints Mark Leuchtenberger as President and CEO investment picks
2014/3/30
EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63 rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States.
Sign-up for Acute Pulmonary Embolism Trial Confirms Safety and Efficacy of Ultrasound Accelerated Endovascular Thrombolysis investment picks
2013/11/22
http://media.marketwire.com/attachments/201311/68896_acutronic.jpg http://media.marketwire.com/attachments/201307/63356_Masimo_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1071071&ProfileId=051205&sourceType=1 ZURICH, SWITZERLAND and IRVINE, CA --
Sign-up for ACUTRONIC Medical Systems Integrates Masimo SET(R) Pulse Oximetry Into fabian HFO Neonatal Critical Care Ventilators for Improved Patient Outcomes investment picks
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service company, today announced a $600 million refinancing.
Sign-up for Acxiom Announces $600 Million Refinancing investment picks
Acxiom® (Nasdaq: ACXM) , an enterprise data, analytics and software-as-a-service company, today announced financial results for its first quarter ended June 30, 2013.
Sign-up for Acxiom Announces First Quarter Results investment picks
2013/11/6
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service company, today announced financial results for its second quarter ended September 30, 2013.
Sign-up for Acxiom Announces Second Quarter Results investment picks
2014/1/29
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service company, today announced financial results for its third quarter ended December 31, 2013.
Sign-up for Acxiom Announces Third Quarter Results investment picks
2014/1/27
Acxiom® (Nasdaq:  ACXM ), the leading enterprise data, analytics and data-driven platform solutions company, today announced the addition of several new features to its Audience Operating System™ (AOS™). Through these enhancements, marketers can: Discover relevant audiences by vertical industry, Re-target email audiences with display campaigns, and Enrich understanding of website visitors through real-time feeds and integrated AOS Hadoop tools.
Sign-up for Acxiom Audience Operating System™ Builds Momentum, Adds New Features investment picks
2014/4/10
Acxiom ® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, has awarded its 2013 Diversity Scholarships to six new information technology students and renewed the scholarship for three recipients from 2012.
Sign-up for Acxiom Awards Diversity Scholarships to Nine College Students investment picks
2014/1/16
Acxiom®, a leading provider of enterprise data, analytics and data-driven platform solutions, announced today that it has entered into a partnership with Twitter, the global platform for public self-expression and conversation in real time.
Sign-up for Acxiom Data Matching Globally Available in Twitter’s New Tailored Audiences Product investment picks
Acxiom® (Nasdaq: ACXM), the leading enterprise data, analytics and software-as-a-service company, today introduced a new way for marketers, agencies and publishers to define, manage and reach best audiences across online and offline channels.
Sign-up for Acxiom Disrupts Conventional Marketing Models with New Audience Operating System (AOS) investment picks
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service company, today announced that the company’s Board of Directors has increased its share repurchase authorization from $200 million to $250 million.
Sign-up for Acxiom Increases Share Repurchase Authorization to $250 Million investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ACTV8.me Launches Personalized Proximity Platform™ for Retail, Travel, Hospitality and Sports/Entertainment Venues with NCR to Acxiom Increases Share Repurchase Authorization to $250 Million
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity